In particular, in cases where VEGF treatment resistance exists (e.g., resistance due to VEGFR2 mutations in diabetic retinopathy), intervening in the circ-MALAT1/miR-96–5p/FOXK2 network may provide an alternative therapeutic strategy. Here, FOXK2 is linked to diabetic retinopathy.